[Angiogenesis as a target for antitumor actions].
Ushmorov
A G
AG
Aleksandrov
V A
VA
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D006131:Growth Inhibitors; D006493:Heparin; D006494:Heparin Antagonists; D006801:Humans; D008934:Mitogens / Q000037:antagonists & inhibitors; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000098:blood supply / Q000188:drug therapy*; D009389:Neovascularization, Pathologic
D000970:Antineoplastic Agents; D006131:Growth Inhibitors; D006494:Heparin Antagonists; D008934:Mitogens; D006493:Heparin
Angiogenez kak mishen' dlia protivoopukholevykh vozdeĭstviĭ.